Risk stratification and treatment for patients with PAH-CHD


12Oct2017 10:00 - 11:00

PhD defence ceremony

The successes of cardiac surgery have resulted in a dramatically increased life expectancy of children with congenital heart disease (CHD). Unfortunately, this prolonged survival puts patients at higher risk for devastating complications such as pulmonary arterial hypertension (PAH). Ilja Blok focuses on risk stratification in adult patients with PAH-CHD, the various treatment options available, new indications for therapy perioperatively and a sports encouragement program for patients with CHD.

I.M. Blok: Congenital Heart Disease and Pulmonary Arterial Hypertension: End of an Era? 


Prof. B.J.M. Mulder


Dr B.J. Bouma


  • Agnietenkapel

    Oudezijds Voorburgwal 229 - 231 | 1012 EZ Amsterdam
    +31 (0)20 525 2362

    Go to detailpage


This event is open to the public.

Published by  University of Amsterdam